DIMACS Working Group on Adverse Event/Disease Reporting, Surveillance, and Analysis I
DIMACS Subgroup on Adverse Event/Disease Reporting, Surveillance, and Analysis
DIMACS Working Group on Adverse Event/Disease Reporting, Surveillance, and Analysis II
| Participants in the Working Group on Adverse Event/Disease Reporting, Surveillance, and Analysis IV
|
|
|---|---|
| Robert Ball | FDA |
| Warren Bilker | University of Pennsylvania |
| John Clarke | Gault Associates |
| Bill DuMouchel | Lincoln Technologies |
| Susan Ellenberg | University of Pennsylvania |
| Aimin Feng | Rutgers Unviersity |
| Victor Gogolak | Drug Logic |
| David Goldsmith | Emory University |
| Manfred Hauben | Pfizer |
| Guillermo Herrera | CDC |
| Martin Kulldorff | Harvard University |
| David Madigan | Rutgers University |
| Lester Reich | Pfizer |
| Henry Rolka | CDC |
| Galit Shmueli | University of Maryland |
| Ivan Zorych | DIMACS |
Previous: Announcement
Next: Program
Workshop Index